HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

Millipore & Roka to Collaborate

Share
September 16, 2009 | Comment(s): 0
Recommended this article (6)
MIL | GPRO | GE

On Monday, Millipore Corp. (MIL - Snapshot Report) announced its collaboration with Roka Bioscience Inc. to develop molecular assays and portable instruments for biopharmaceutical production.
 
Roka Bioscience is a new, independent company created following the spin-off of the industrial testing business of Gen-Probe Inc. (GPRO - Analyst Report). After the spin-off, Gen-Probe transferred its partnership agreements with Millipore and GE Water (a business unit of CT-based General Electric (GE - Analyst Report). Roka Bioscience is now engaged in developing real-time molecular tests for biopharmaceutical, food, and water safety testing.
 
Gen-Probe initially plans to own 19.9% of the new company. Affiliates of three private equity firms, OrbiMed Advisors, TPG Biotechnology and New Enterprise Associates have agreed to provide $37.2 million to complete the development of several industrial-scale molecular assays. Gen-Probe contributed industrial assets that include its closed unit dose assay (CUDA) system, a portable testing instrument that can deliver highly accurate molecular results in roughly an hour.
 
Millipore and Gen-Probe formed an exclusive partnership in 2005 to develop faster, more reliable and sensitive tests for contaminants commonly found in pharmaceutical and biotechnology manufacturing processes. In 2008, they introduced the MilliPROBE® system, which is the first solution of its kind and combines Millipore’s leading industry-accepted sample prep methodologies with Gen-Probe’s advanced proven nucleic acid technologies to deliver both speed and sensitivity in one microbial screening tool.
 
The companies currently have one assay on the market for Pseudomonas aeruginosa and are developing a second assay for Mycoplasma that remains on track to be introduced early in 2010.
 
Roka Bioscience’s investment into a fully integrated, portable testing instrument will help Millipore accelerate further development of MilliPROBE assays.

Read the full analyst report on MIL

Read the full analyst report on GPRO

Read the full analyst report on GE

 

Please login to Zacks.com or register to post a comment.


Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 25, 2012 20:48 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center